medigraphic.com
SPANISH

Revista Cubana de Farmacia

ISSN 1561-2988 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 2

<< Back Next >>

Rev Cubana Farm 2014; 48 (2)

Validation of the quality control methods for active ingredients of Fungirex cream

Pérez NM, Rodríguez HY, Suárez PY
Full text How to cite this article

Language: Spanish
References: 8
Page: 213-224
PDF size: 203.83 Kb.


Key words:

validation, complexometry, neutralization volumetry, undecylenic acid, zinc undecylenate, cream.

ABSTRACT

Introduction: Fungirex cream is a two-drug product, that is, undecylenic acid and zinc undecylenate over a suitable basis. Since this is a product not documented in the official monographs of the pharmacopeae, simple analytical methods were suggested for quantitation of analytes of interest in the cream, which are useful for release of newly prepared cream batches.
Objective: to validate two volumetric methods for the quality control of active ingredients in Fungirex cream.
Methods: a direct neutralization volumetric method was suggested to quantitate undecylenic acid after the analyte extraction and EDTA complexometry for zinc undecylenate. According to the classification of both methods in the category I, they were validated through the parameters specificity, linearity, accuracy, precision and range.
Results: the non-interference of the rest of the matrix components was corroborated. The set acceptance criteria for linearity, accuracy and precision were satisfactorily met for the two study methods, so they were valid in the 50-150 % range (neutralization volumetry method: 25.6-76.8 mg/g and complexometry method 111.1-333,3 mg/g).
Conclusions: the suggested volumetric methods were linear, specific, precise, and accurate for the quality control of Fungirex cream based on the undecylenic acid and zinc undecylenate content.


REFERENCES

  1. Mediavilla A, Flórez J. Farmacología humana. En: Farmacología clínica dermatológica. 3ra ed. Barcelona: Masson SA; 1997. p. 1256.

  2. Ministerio de Salud Pública. Centro para el Desarrollo de la Farmacoepidemiología. Formulario Nacional de Medicamentos. Capítulo 13. Antimicóticos [CD-ROM]. La Habana: Ed Ciencias Médicas; 2006. p. 301.

  3. Suárez Y, Rosales E, González M, Álvarez A, Castiñeira M. Desarrollo y validación de los métodos analíticos para el control de calidad del micocilén polvo. Rev Cubana Farm. 2011;45(2):190-204.

  4. British Pharmacopoeia Volume I & II Monographs: Medicinal and Pharmaceutical [CD-ROM]. London: The Stationery Office; 2009.

  5. USP 32. United States Pharmacopoeia XXXII and National Formulary 27: United States Pharmacopeial Convention [CD-ROM]. New York: Pharm Convention Inc.; 2009

  6. Regulación 37-2012. Buenas Prácticas de Laboratorio para el Control de Medicamentos. Ministerio de Salud Pública. La Habana, Cuba. 2012. p 17.

  7. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Validation of analytical procedures: text and methodology. Q2(R1). New York: Food and Drug Administration; 2005. p. 1-2.

  8. Regulación 41-2007. Validación de métodos analíticos. Centro para el Control Estatal de la Calidad de los Medicamentos (CECMED). Ministerio de Salud Pública. La Habana, Cuba. 2007. p. 6-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Farm. 2014;48